InvestorsHub Logo
icon url

longfellow95

08/05/21 5:08 PM

#393959 RE: jondoeuk #393958

"The efficacy of anti-CTLA-4, anti-PD-1, anti-PD-L1 and TIL is due to neoantigen reactive T-cells."

Do you mean the very limited efficacy?!